JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB7755

Anti-Cytokeratin 19 抗体 [BA-17]

Anti-Cytokeratin 19 antibody [BA-17]

4

(5 Reviews)

|

(28 Publications)

Mouse Monoclonal Cytokeratin 19 antibody. Suitable for IP, WB, ICC/IF, Flow Cyt (Intra), IHC-P and reacts with Human samples. Cited in 28 publications. Immunogen corresponding to Tissue preparation containing KRT19 protein.

別名を表示する

Cytokeratin-19, Keratin-19, CK-19, K19, KRT19, ck19, ck 19

8 Images
Flow Cytometry (Intracellular) - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)
  • Flow Cyt (Intra)

Supplier Data

Flow Cytometry (Intracellular) - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)

Separation of MCF-7 cells (red-filled) from human leukocytes (black-dashed) in flow cytometry analysis (intracellular staining) of peripheral whole blood spiked with MCF-7 cells stained using ab7755 (concentration in sample 3 μg/ml, GAM APC).

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)

Human normal skin. Staining is observed in the cytoplasm (epidermal basal cells). Left panel : with primary antibody at 2 ug/ml. Right panel : isotype control. Sections were stained using an automated system DAKO Autostainer Plus , at room temperature : sections were rehydrated and antigen retrieved with the Dako 3 in 1 AR buffers citrate EDTA pH 9.0 in a DAKO PT Link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 mins. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS) then incubated with primary antibody for 20 min and detected with Dako envision flex amplification kit for mouse for 30 minutes. Colorimetric detection was completed with Diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be required.

Flow Cytometry (Intracellular) - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)
  • Flow Cyt (Intra)

Unknown

Flow Cytometry (Intracellular) - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)

Overlay histogram showing MCF7 cells stained with ab7755 (red line). The cells were fixed with 80% methanol (5 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody (ab7755, 1μg/1x106 cells) for 30 min at 22°C. The secondary antibody used was DyLight® 488 goat anti-mouse IgG (H+L) (ab96879) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was mouse IgG1 [ICIGG1] (ab91353, 2μg/1x106 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in MCF7 cells fixed with 4% paraformaldehyde (10 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.

Immunocytochemistry - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)
  • ICC

Supplier Data

Immunocytochemistry - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)

ab7755 staining Cytokeratin 19 in wild-type MCF7 cells (top panel) and KRT19 knockout MCF7 cells (bottom panel). The cells were fixed with 100% methanol (5 min), permeabilized with 0.1% Triton X-100 for 5 minutes and then blocked with 1% BSA/10% normal goat serum/0.3M glycine in 0.1% PBS-Tween for 1h. The cells were then incubated with ab7755 at 5μg/ml concentration and ab6046 (Rabbit polyclonal to beta Tubulin) at 1/1000 dilution overnight at +4°C, followed by a further incubation at room temperature for 1h with a goat secondary antibody to mouse IgG (Alexa Fluor® 488) (ab150117) at 2 μg/ml (shown in green) and a goat secondary antibody to rabbit IgG (Alexa Fluor® 594) (ab150080) at 2 μg/ml (shown in red). Nuclear DNA was labelled in blue with DAPI.
Image was taken with a confocal microscope (Leica-Microsystems, TCS SP8).

Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)

ICC/IF image of ab7755 stained HepG2 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab7755, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-mouse IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

Immunoprecipitation - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)
  • IP

Unknown

Immunoprecipitation - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)

Cytokeratin 19 was immunoprecipitated using 0.5mg HepG2 whole cell extract, 5µg of Mouse monoclonal to Cytokeratin 19 and 50µl of protein G magnetic beads (+). No antibody was added to the control (-).
The antibody was incubated under agitation with Protein G beads for 10min, HepG2 whole cell extract lysate diluted in RIPA buffer was added to each sample and incubated for a further 10min under agitation.
Proteins were eluted by addition of 40µl SDS loading buffer and incubated for 10min at 70oC; 10µl of each sample was separated on a SDS PAGE gel, transferred to a nitrocellulose membrane, blocked with 5% BSA and probed with ab7755.
Secondary : Goat polyclonal to mouse IgG light chain specific (HRP) at 1/5000 dilution.
Band : 44kDa : Cytokeratin 19

All lanes:

Immunoprecipitation - Anti-Cytokeratin 19 antibody [BA-17] (ab7755)

Predicted band size: 44 kDa

false

Western blot - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)
  • WB

Unknown

Western blot - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)

All lanes:

Western blot - Anti-Cytokeratin 19 antibody [BA-17] (ab7755) at 5 µg/mL

Lane 1:

HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate at 10 µg

Lane 2:

SW480 (Human colon adenocarcinoma cell line) Whole Cell Lysate at 10 µg

Lane 3:

MDA-MB-361 (Human breast adenocarcinoma cell line) Whole Cell Lysate at 10 µg

Secondary

All lanes:

Goat polyclonal to Mouse IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Predicted band size: 44 kDa

Observed band size: 44 kDa

false

Western blot - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)
  • WB

Unknown

Western blot - Anti-Cytokeratin 19 antibody [BA-17] (AB7755)

All lanes:

Western blot - Anti-Cytokeratin 19 antibody [BA-17] (ab7755)

All lanes:

Cell lysates prepared from human MCF-7 cells

Predicted band size: 44 kDa

false

Key facts

宿主種

Mouse

クローン性

Monoclonal

クローン番号

BA-17

アイソタイプ

IgG1

キャリアフリー

No

交差種

Human

アプリケーション

ICC/IF, IHC-P, Flow Cyt (Intra), IP, WB

applications

免疫原

Tissue preparation containing KRT19 protein. The exact immunogen used to generate this antibody is proprietary information.

P08727

特異性

Cytokeratin peptide 19 (40 kDa) in human tissue.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"}, "FlowCytIntra" : {"fullname" : "Flow Cytometry (Intracellular)", "shortname":"Flow Cyt (Intra)"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1-2 µg/mL", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>", "FlowCytIntra-species-checked": "testedAndGuaranteed", "FlowCytIntra-species-dilution-info": "1-5 µg/mL", "FlowCytIntra-species-notes": "<p><a href='/products/primary-antibodies/mouse-igg1-kappa-monoclonal-15-6e10a7-isotype-control-ab170190'>ab170190</a> - Mouse monoclonal IgG1, is suitable for use as an isotype control with this antibody.</p>", "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "5-10 µg/mL", "IHCP-species-notes": "<p></p> Perform enzymatic antigen retrieval before commencing with IHC staining protocol." } } }

出荷温度及び保存条件

製品の状態
Liquid
精製方法
Affinity purification Protein A
バッファー組成
pH: 7.4 Preservative: 0.097% Sodium azide Constituents: PBS
出荷温度
Blue Ice
短期保存期間
1-2 weeks
短期保存温度
+4°C
長期保存温度
-20°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Cytokeratin 19 (CK19) also known as cytokera­tine 19 keratin 19 (KRT19) or CK19 is a type of intermediate filament found in epithelial cells. It serves as an essential component of the cytoskeleton. CK19 weighs approximately 40 kDa and is broadly expressed in simple epithelial tissues including liver intestine and various glandular epithelial cells. As a cytokeratin marker it often appears in combination with others like cytokeratin 17 in certain tissue types helping to maintain the structural integrity of cells.
Biological function summary

CK19 plays a role in maintaining the cytoskeletal framework that provides mechanical support and helps control cell size and shape. It is not part of a large protein complex but works closely with other cytokeratins to ensure the stability and resilience of epithelial tissues. The A53-B/A22.26 positive staining is often used to confirm its presence in clinical histopathology.

Pathways

CK19 connects to cellular processes especially involving the keratinization and epithelial cell differentiation pathways. It interacts with other cytokeratins including BA16 and KR17 to facilitate these processes. This interaction aids in modulating the dynamics of cytoskeletal rearrangement during cell movement division and differentiation.

CK19 overexpression is linked with certain cancers notably hepatocellular carcinoma and breast cancer. It can serve as a prognostic marker in these diseases often in conjunction with other markers like CK17. The involvement of CK19 in the epithelial-mesenchymal transition (EMT) process connects it to the progression and aggressiveness of tumors facilitated by interactions with proteins involved in EMT pathways.

製品プロトコール

For this product, it's our understanding that no specific protocols are required. You can visit:

ターゲットの情報

Involved in the organization of myofibers. Together with KRT8, helps to link the contractile apparatus to dystrophin at the costameres of striated muscle.
See full target information KRT19

文献 (28)

Recent publications for all applications. Explore the full list and refine your search

Proceedings of the National Academy of Sciences of the United States of America 122:e2426218122 PubMed40591600

2025

Signal peptide-independent secretion of keratin-19 by pancreatic cancer cells.

Applications

Unspecified application

Species

Unspecified reactive species

Philip Moresco,Jonathan P Kastan,Jung-In Yang,Rishvanth Prabakar,Z Larkin Kelley,Francesca Minicozzi,Dexter W Adams,Paolo Cifani,David A Tuveson,Douglas T Fearon

Regenerative therapy 30:1-8 PubMed40476159

2025

Transplantation of chemically induced liver progenitors in Nagase analbuminemic rats under liver regenerative stimulus.

Applications

Unspecified application

Species

Unspecified reactive species

Masayuki Fukumoto,Akihiko Soyama,Daisuke Miyamoto,Takanobu Hara,Hajime Matsushima,Hajime Imamura,Mampei Yamashita,Tomohiko Adachi,Kengo Kanetaka,Susumu Eguchi

Bioactive materials 47:170-180 PubMed39906644

2025

Full-thickness cervix reconstruction via collagen scaffolds in rabbits.

Applications

Unspecified application

Species

Unspecified reactive species

Yaqian Li,Weijie Tian,Jianbin Guo,Yang Ye,Qianqian Gao,Yiwei Zhang,Xiaoyue Zhao,Jianwu Dai,Lan Zhu

Journal of endocrinological investigation 48:653-670 PubMed39453570

2024

Estrogen enhances the proliferation, migration, and invasion of papillary thyroid carcinoma via the ERα/KRT19 signaling axis.

Applications

Unspecified application

Species

Unspecified reactive species

Z M Song,Y D Wang,F Chai,J Zhang,S Lv,J X Wang,Y Xi

Nature cancer 4:1362-1381 PubMed37679568

2023

Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC.

Applications

Unspecified application

Species

Unspecified reactive species

Xu Zhou,Jingyu An,Roma Kurilov,Benedikt Brors,Kai Hu,Teresa Peccerella,Stephanie Roessler,Katrin Pfütze,Angela Schulz,Stephan Wolf,Nicolas Hohmann,Dirk Theile,Max Sauter,Jürgen Burhenne,Shigenori Ei,Ulrike Heger,Oliver Strobel,Simon T Barry,Christoph Springfeld,Christine Tjaden,Frank Bergmann,Markus Büchler,Thilo Hackert,Franco Fortunato,John P Neoptolemos,Peter Bailey

FEBS open bio 13:898-911 PubMed36929584

2023

Reversine attenuates cholestatic ductular reaction in rats.

Applications

Unspecified application

Species

Unspecified reactive species

Di Huang,Lijuan Tang,Tianyang Li,Peilin Li,Zisheng Huang,Jiefeng Weng,Shuai Zhang,Weili Gu,Yu Huang

Cancer biology & medicine 20: PubMed36971107

2023

Artificial intelligence-based comprehensive analysis of immune-stemness-tumor budding profile to predict survival of patients with pancreatic adenocarcinoma.

Applications

Unspecified application

Species

Unspecified reactive species

Tianxing Zhou,Quan Man,Xueyang Li,Yongjie Xie,Xupeng Hou,Hailong Wang,Jingrui Yan,Xueqing Wei,Weiwei Bai,Ziyun Liu,Jing Liu,Jihui Hao

Cell death & disease 13:1074 PubMed36572673

2022

Loss of tumor suppressor WWOX accelerates pancreatic cancer development through promotion of TGFβ/BMP2 signaling.

Applications

Unspecified application

Species

Unspecified reactive species

Hussam Husanie,Muhannad Abu-Remaileh,Kian Maroun,Lina Abu-Tair,Hazem Safadi,Karine Atlan,Talia Golan,Rami I Aqeilan

Cell adhesion & migration 16:13-24 PubMed35137648

2022

TNF-α regulates the composition of the basal lamina and cell-matrix adhesions in gingival epithelial cells.

Applications

Unspecified application

Species

Unspecified reactive species

Masaru Mezawa,Yuto Tsuruya,Arisa Yamaguchi,Mizuho Yamazaki-Takai,Tetsuro Kono,Hiroyuki Okada,Christopher A McCulloch,Yorimasa Ogata

Cell biochemistry and function 38:817-825 PubMed32515027

2020

Changes of Endocan and its effect on hepatic stem cells during the rapid proliferation process of residual liver after ALPPS procedure.

Applications

Unspecified application

Species

Unspecified reactive species

Liang Zhao,Chaoliu Dai,Qi Gong
View all publications

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com